Integrated Shield Plans

<h1>Integrated Shield Plans</h1> <p>Integrated Shield Plans (IPs) are Singapore's optional private hospital-insurance policies that layer additional coverage on top of compulsory <a href="/en/knowledge/article/sgkb.healthcare.healthcare-financing">MediShield Life</a>, which every Singapore citizen and permanent resident already holds. An IP is <strong>not</strong> a substitute for MediShield Life: it is sold by a licensed private insurer as a single integrated policy whose MediShield Life component remains sized for subsidised Class B2/C care in public hospitals, while the insurer's add-on targets higher ward classes or private hospitals (<a href="https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/integrated-shield-plans/about-integrated-shield-plans/">MOH, accessed Aug 2026</a>). Roughly two-thirds of Singapore residents hold an IP — about 2.86 million policyholders as of 2021 (<a href="https://www.moh.gov.sg/others/resources-and-statistics/government-health-expenditure-and-healthcare-financing/">MOH statistics, accessed Aug 2026</a>) — making IPs central to how middle- and upper-income Singaporeans finance unsubsidised hospital care, even though MediShield Life alone remains adequate for subsidised public wards. Dated Additional Withdrawal Limits, minimum deductibles, and rider rules are tabulated in <a href="/en/knowledge/dataset/sgkb.data.integrated-shield-anchors">integrated shield anchors</a>; this article does not quote insurer-specific commercial premium schedules that change by age, tier, and underwriting.</p> <h2>How IPs extend MediShield Life</h2> <p>An Integrated Shield Plan has two legally distinct but administratively unified parts. The <strong>MediShield Life component</strong> is run by the CPF Board and cannot be opted out of; it covers large hospital bills and selected high-cost outpatient treatments, with benefits pegged to subsidised B2/C wards. The <strong>additional private insurance component</strong> is underwritten by the insurer and pays for care above that baseline — Class B1, A, or private-hospital treatment, direct specialist access without a subsidised referral, and typically higher annual claim limits (<a href="https://www.cpf.gov.sg/member/healthcare-financing/getting-supplementary-coverage/integrated-shield-plan">CPF Board, accessed Aug 2026</a>). The private insurer is the policyholder's single point of contact: it collects the combined premium, processes claims, and acts for the CPF Board on the MediShield Life portion (<a href="https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/integrated-shield-plans/about-integrated-shield-plans/">MOH, accessed Aug 2026</a>).</p> <p>MediShield Life within an IP continues for life and covers pre-existing conditions even when the insurer's add-on excludes them. A resident may hold only one IP at a time; switching insurers is permitted but underwriting rules apply to the new private component. MOH publishes side-by-side comparison tables of every licensed plan's benefits, deductibles, and common claim-rejection reasons — notably, about 69% of claims that pay nothing on the private component do so because the bill falls at or below the annual deductible (<a href="https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/integrated-shield-plans/comparision-of-integrated-shield-plans/">MOH comparison tables, accessed Aug 2026</a>). Hospital subsidy rules under MOH means testing are separate from IP entitlement; a patient in a subsidised C ward still receives ward subsidies, while an IP's payout depends on the purchased tier (see <a href="/en/knowledge/article/sgkb.healthcare.hospitals">hospitals</a>).</p> <h2>Coverage tiers and insurers</h2> <p>Seven private insurers are licensed to sell IPs: AIA, Great Eastern, HSBC Life, Income, Prudential, Raffles Health Insurance, and Singlife (<a href="https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/integrated-shield-plans/comparision-of-integrated-shield-plans/">MOH comparison tables, accessed Aug 2026</a>). Plans are grouped by the ward class they target, in ascending cost and breadth:</p> <table> <thead> <tr> <th>Tier</th> <th>Typical target</th> <th>Distinctive feature</th> </tr> </thead> <tbody> <tr> <td>Standard B1</td> <td>Class B1 in public hospitals</td> <td>Benefits are <strong>identical across all seven insurers</strong> by MOH mandate; only premiums differ</td> </tr> <tr> <td>Enhanced B1</td> <td>Class B1 with higher limits</td> <td>Insurers compete on annual limits and &quot;as-charged&quot; sub-limits</td> </tr> <tr> <td>Class A</td> <td>Class A in public hospitals</td> <td>Single-bedded rooms, choice of specialist; higher policy-year limits</td> </tr> <tr> <td>Private hospital</td> <td>Private hospitals</td> <td>Highest tier; most plans offer as-charged coverage with limits typically from about S$1 million upward</td> </tr> </tbody> </table> <p>Choosing a tier above what a patient actually uses triggers <strong>pro-ration</strong>: staying in a ward class higher than the plan's target leaves a larger share of the bill uninsured. A private-hospital IP used for a subsidised B2/C stay still pays, but less generously than for its intended setting (<a href="https://www.cpf.gov.sg/content/dam/web/member/healthcare/documents/Claim%20Illustrations%20and%20Benefits%20Premiums%20Comparisons.pdf">CPF Board claim illustrations, accessed Aug 2026</a>). Insurers maintain <strong>main panels</strong> of specialists offering pre-authorisation and lower co-payment; an industry <strong>Extended Panel</strong> framework extends some panel benefits to selected off-panel doctors (<a href="https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/integrated-shield-plans/about-integrated-shield-plans/">MOH, accessed Aug 2026</a>). As of 2023, 38% of citizens and permanent residents held the highest private-hospital tier, down from 40% in 2021, while uptake among those aged 60 and below continued to rise (<a href="https://www.straitstimes.com/singapore/fewer-people-on-private-hospital-ips-more-older-people-giving-up-their-plans-altogether">ST, Apr 2024</a>).</p> <h2>Premiums, deductibles, and co-payment</h2> <p>IP premiums rise steeply with age. The CPF Board notes that the private component alone can reach several times MediShield Life premiums for someone in their 70s or 80s (<a href="https://www.cpf.gov.sg/member/healthcare-financing/getting-supplementary-coverage/integrated-shield-plan">CPF Board, accessed Aug 2026</a>). MediShield Life premiums within the IP are fully payable from MediSave; the private component is MediSave-payable only up to <strong>Additional Withdrawal Limits</strong> by age next birthday — S$300 (ages 1–40), S$600 (41–70), and S$900 (71 and above) — with any excess in cash (<a href="/en/knowledge/dataset/sgkb.data.integrated-shield-anchors">integrated shield anchors</a>; <a href="https://www.cpf.gov.sg/service/article/what-are-additional-withdrawal-limits-awls-for-integrated-shield-plan-ip-premiums">CPF Board AWL guidance, accessed Aug 2026</a>). MOH regulates premium <strong>structure</strong> and cost-sharing parameters but not each insurer’s commercial price list; insurers reprice annually and must give 30 days' notice (<a href="https://www.moh.gov.sg/newsroom/measures-to-manage-increases-to-base-integrated-shield-plan-premiums/">MOH, accessed Aug 2026</a>). Between December 2021 and December 2024, private-hospital base IP premiums rose at an average compound rate of 8.6% per year and private-hospital rider premiums at 17.2% — industry aggregates, not a resident’s renewal quotation (<a href="https://www.moh.gov.sg/newsroom/measures-to-manage-increases-to-base-integrated-shield-plan-premiums/">MOH, accessed Aug 2026</a>).</p> <p>Every IP must carry MOH-set <strong>minimum deductibles</strong> per policy year (payable once, accumulable across bills): S$1,500 for Class C, S$2,000 for B2, S$2,500 for B1, and S$3,500 for Class A or private hospitals, with the applicable amount being the lower of the plan's target tier and the ward actually used (<a href="https://www.moh.gov.sg/newsroom/new-requirements-for-integrated-shield-plan-riders-to-strengthen-sustainability-of-private-health-insurance-and-address-rising-healthcare-costs/">MOH Nov 2025 rider announcement, accessed Aug 2026</a>). After the deductible, the patient pays <strong>10% co-insurance</strong> on the remainder (capped annually per MOH tables), preserving co-payment even within insurance. Deductibles and co-insurance can be paid from MediSave subject to withdrawal limits. MOH's general practice is not to intervene in premium levels, but it does set these cost-sharing parameters so IPs remain sustainable alongside subsidised care.</p> <h2>Critical perspectives: riders and sustainability reforms</h2> <p><strong>Riders</strong> are optional cash-paid add-ons that further reduce out-of-pocket costs on top of the main IP. Before 2018, &quot;full&quot; riders could cover the entire deductible and co-insurance — first-dollar coverage that MOH linked to over-servicing, over-charging, and rapidly rising claims: between 2015 and 2020, full-rider claim incidence grew at about 15% compound annual rate for private-hospital IPs, with average bill sizes at least 20% above riders that retained some co-payment (<a href="https://www.moh.gov.sg/newsroom/co-payment-in-integrated-shield-plans-for-specific-hospital-categories-and-breakdown-of-average-claims-made-through-full-riders-of-integrated-shield-plans/">MOH, accessed Aug 2026</a>).</p> <p>From <strong>1 April 2019</strong>, all new riders must include at least <strong>5% co-payment</strong>, with insurers typically capping annual co-payment at S$3,000 for panel or pre-authorised treatment (higher caps are permitted; non-panel care has no cap). Legacy full riders bought before March 2018 were grandfathered initially, but insurers have since migrated many holders onto co-payment designs. In <strong>November 2025</strong>, MOH announced a second tightening effective <strong>1 April 2026</strong>: new riders may no longer cover MOH minimum deductibles, and the minimum annual co-payment cap rises from S$3,000 to <strong>S$6,000</strong> (excluding the deductible). MOH expects new compliant riders to cost about 30% less on average than maximum-coverage legacy riders, with all seven insurers launching compliant products by April 2026 (<a href="https://www.moh.gov.sg/newsroom/new-requirements-for-integrated-shield-plan-riders-to-strengthen-sustainability-of-private-health-insurance-and-address-rising-healthcare-costs/">MOH, accessed Aug 2026</a>). Policyholders who bought non-compliant riders on or after 27 November 2025 must transition at their next renewal after 1 April 2028. Rider premiums must be paid entirely in cash — they are not MediSave-deductible.</p> <p>The policy arc reflects MOH's view that insurance should protect against catastrophic bills, not eliminate all co-payment on routine episodes. Private-hospital IP holders with riders were 1.4 times as likely to claim and at 1.4 times the average claim size of those without riders, feeding a &quot;knot&quot; of rising bills and premiums that MOH is also addressing through fee benchmarks, claims enforcement, and exploration of a not-for-profit private hospital (<a href="https://www.moh.gov.sg/newsroom/new-requirements-for-integrated-shield-plan-riders-to-strengthen-sustainability-of-private-health-insurance-and-address-rising-healthcare-costs/">MOH, accessed Aug 2026</a>).</p> <h2>Choosing and maintaining coverage</h2> <p>A resident who is comfortable with subsidised B2/C wards in public hospitals and does not need to choose a specialist without referral may find MediShield Life sufficient; the CPF Board explicitly frames that as the default for cost-conscious households (<a href="https://www.cpf.gov.sg/member/healthcare-financing/getting-supplementary-coverage/integrated-shield-plan">CPF Board, accessed Aug 2026</a>). An IP becomes relevant for Class A or B1 preference, private-hospital access, or unrestricted specialist choice. The decision turns on long-term affordability: premiums escalate with age, cash top-ups above AWLs grow, and downgrading or lapsing later may face underwriting exclusions on the private component.</p> <p>Coverage status can be checked on the CPF Healthcare dashboard via Singpass. Disputes with insurers go to the Financial Industry Disputes Resolution Centre under MAS insurance regulations. Between 2020 and 2023, 2.2% of residents aged over 60 surrendered their IPs entirely, reverting to MediShield Life alone, even as younger cohorts continued to buy in (<a href="https://www.straitstimes.com/singapore/fewer-people-on-private-hospital-ips-more-older-people-giving-up-their-plans-altogether">ST, Apr 2024</a>). The wider financing context — subsidies, MediSave, MediFund, and CareShield Life for long-term disability — is covered in <a href="/en/knowledge/article/sgkb.healthcare.healthcare-financing">healthcare financing</a>; ward-class and referral mechanics that determine subsidy and insurance interaction are in <a href="/en/knowledge/article/sgkb.healthcare.hospitals">hospitals</a> and <a href="/en/knowledge/article/sgkb.healthcare.polyclinics-and-primary-care">polyclinics and primary care</a>.</p> <h2>Challenging an Integrated Shield Plan claim decision</h2> <p>If an insurer declines or appears to miscalculate a health-insurance claim, the policyholder should first send the complaint and supporting explanation to the insurer, including the policy number and relevant medical bills, invoices, receipts or reports. Keep the insurer's written response. FIDReC requires consumers to approach the financial institution first; it may accept a complaint after the institution's internal dispute process has not resolved it or after four weeks from referral to the institution, whichever is earlier. A consumer must file no later than six months after receiving the insurer's final reply. FIDReC's insurance guide says it assists individuals or sole proprietors and checks each case against its jurisdiction rules; insurers are among the subscribing financial institutions (<a href="https://www.fidrec.com.sg/knowledgebase/article/KA-01259/en-us">FIDReC, <em>Consumer's Guide to Life Insurance Disputes</em>, accessed 15 November 2026</a>; <a href="https://www.fidrec.com.sg/knowledgebase/article/KA-01013">FIDReC, <em>FAQs</em>, accessed 15 November 2026</a>).</p> <p>For a health-insurance complaint, FIDReC lists the policy contract and schedule, correspondence with the insurer, and medical bills, invoices, receipts and medical reports as supporting documents; group-health policyholders may also need written HR approval. FIDReC first offers mediation, and a consumer may choose adjudication if mediation does not resolve the dispute. An adjudication decision binds the financial institution but not the consumer; there is no appeal within FIDReC, and the consumer may reject the decision and pursue other avenues (<a href="https://www.fidrec.com.sg/knowledgebase/article/KA-01325/en-us">FIDReC, <em>List of Supporting Documents</em>, accessed 15 November 2026</a>; <a href="https://www.fidrec.com.sg/knowledgebase/article/KA-01013">FIDReC, <em>FAQs</em>, accessed 15 November 2026</a>). These are routes for disputes with the insurer; they do not describe how to correct a hospital's billing or a MediSave/MediShield Life submission.</p>

简介

综合健保计划

综合健保计划(IP)是新加坡的自选私人住院保险保单,在强制性终身健保之上提供额外保障;每位新加坡公民和永久居民都已持有终身健保。IP 不能替代终身健保:IP 由获许可的私人保险公司以单一整合保单形式出售,其中的终身健保部分仍按公立医院享有津贴的 B2/C 级病房保障额度设计,而保险公司的附加部分则针对更高级别病房或私立医院就医(MOH,查阅于 2026 年八月)。约三分之二的新加坡居民持有 IP——截至 2021 年约有 2.86 百万名保单持有人(MOH 统计数据,查阅于 2026 年八月)——因此,对中高收入新加坡人而言,IP 是支付无津贴住院护理费用的重要方式,尽管单靠终身健保仍足以支付享有津贴的公立病房费用。注明日期的额外提款限额、最低免赔额和附加险规则列于综合健保计划关键数据;本文不列出会随年龄、等级和核保情况变化的各保险公司商业保费表。

IP 如何扩展终身健保的保障

综合健保计划包含两个法律上有别、但行政管理上统一的部分。终身健保部分由公积金局管理,不能退出;它承保大额住院账单和部分高额门诊治疗,给付额度以享有津贴的 B2/C 级病房为基准。私人保险附加部分由保险公司承保,支付超出这项基本保障的护理费用——包括 B1、A 级病房或私立医院治疗、无需津贴转介即可直接看专科医生,以及通常更高的年度理赔限额(CPF Board,查阅于 2026 年八月)。私人保险公司是保单持有人的单一联络窗口:它收取合并保费、处理理赔,并代表公积金局处理终身健保部分(MOH,查阅于 2026 年八月)。

IP 内的终身健保终身有效,即使保险公司的附加保障将既有疾病排除在外,终身健保仍承保这些疾病。居民同一时间只能持有一份 IP;可以更换保险公司,但新私人保险部分须遵守核保规则。MOH 发布并列比较表,列出所有获许可计划的保障、免赔额和常见拒赔原因——值得注意的是,私人保险部分约 69% 未获任何赔付的理赔,是因为账单金额不超过年度免赔额(MOH 比较表,查阅于 2026 年八月)。MOH 经济状况审查下的医院津贴规则与 IP 资格分开处理;住在享有津贴的 C 级病房的病人仍可获得病房津贴,而 IP 的赔付则取决于所购买的等级(见医院)。

保障等级和保险公司

有 七家私人保险公司获许可销售 IP:AIA、Great Eastern、HSBC Life、Income、Prudential、Raffles Health Insurance 和 Singlife(MOH 比较表,查阅于 2026 年八月)。计划按目标病房等级分组,保障范围和费用依次递增:

等级 常见目标 特点
标准 B1 公立医院 B1 级病房 根据 MOH 要求,七家保险公司的保障完全相同;只有保费不同
增强型 B1 B1 级病房,较高限额 保险公司在年度限额和“按实际收费”子限额方面展开竞争
A 级 公立医院 A 级病房 单人病房,可选择专科医生;保单年度限额较高
私立医院 私立医院 最高等级;大多数计划提供按实际收费的保障,限额通常从约 S$1 百万新元起

选择高于病人实际使用等级的计划会触发按比例赔付:入住高于计划目标等级的病房,会使账单中未获保险赔付的比例增大。用于享有津贴的 B2/C 级病房住院的私立医院 IP 仍会赔付,但赔付力度低于计划的目标就医环境(CPF Board 理赔示例,查阅于 2026 年八月)。保险公司设有专科医生主要名单,名单内的医生提供预先授权并收取较低的共同承担费用;行业扩展名单机制则将部分名单福利扩展至经过筛选的名单外医生(MOH,查阅于 2026 年八月)。截至 2023 年,38% 的公民和永久居民持有最高级别的私立医院计划,低于 2021 年的 40%;与此同时,60 岁及以下人群中的投保率继续上升(ST,2024 年四月)。

保费、免赔额和共同承担费用

IP 保费随年龄大幅上涨。CPF Board 指出,对于 70或 80多岁的人,私人保险部分的保费可能达到终身健保保费的数倍(CPF Board,查阅于 2026 年八月)。IP 内的终身健保保费可全额使用 MediSave 支付;私人保险部分只能在按下一个生日年龄计算的额外提款限额内使用 MediSave 支付——1 至 40 岁为 S$300,41 至 70 岁为 S$600,71 岁及以上为 S$900;超出部分须以现金支付(综合健保计划关键数据;CPF Board 额外提款限额指南,查阅于 2026 年八月)。MOH 监管保费结构和分担费用参数,但不规定各保险公司的商业价目表;保险公司每年重新定价,并须提前 30 天通知(MOH,查阅于 2026 年八月)。2021 年十二月至 2024 年十二月期间,私立医院基础 IP 保费的年均复合增长率为 8.6%,私立医院附加险保费为 17.2%——这些是行业汇总数据,并非居民个人的续保报价(MOH,查阅于 2026 年八月)。

每份 IP 必须遵守 MOH 规定的最低免赔额,按保单年度计算(每年支付一次,可由多张账单累计):C 级为 S$1,500,B2 级为 S$2,000,B1 级为 S$2,500,A 级或私立医院为 S$3,500;适用金额取计划目标等级和实际入住病房等级两者中较低者(MOH 2025 年十一月附加险公告,查阅于 2026 年八月)。支付免赔额后,病人须对剩余金额承担 10% 的共同保险费用(每年设有 MOH 表格规定的上限),因此即使投保仍须共同承担费用。免赔额和共同保险费用可在提款限额范围内使用 MediSave 支付。MOH 通常不会干预保费水平,但会设定这些分担费用参数,使 IP 与享有津贴的医疗服务一并保持可持续。

重要观点:附加险和可持续性改革

附加险是自选的现金付费保障,在主要 IP 之上进一步减少自付费用。2018 年以前,“全额”附加险可以覆盖全部免赔额和共同保险费用——这种首元全赔保障被 MOH 认为与过度服务、超额收费和理赔快速增加有关:2015 年至 2020 年间,私立医院 IP 全额附加险的理赔率以约 15% 的复合年增长率上升,平均账单金额至少比保留部分共同承担费用的附加险高 20%(MOH,查阅于 2026 年八月)。

自 2019 年四月 1 日起,所有新附加险必须包含至少 5% 的共同承担费用;对于通过名单内医生或经预先授权的治疗,保险公司通常将年度共同承担费用上限设为 S$3,000(允许更高上限;名单外治疗没有上限)。2018 年三月前购买的旧有全额附加险最初获准继续保留,但此后保险公司已将许多持有人的计划转换为需要共同承担费用的设计。2025 年十一月,MOH 宣布从 2026 年四月 1 日起进一步收紧规定:新附加险不得再覆盖 MOH 规定的最低免赔额,最低年度共同承担费用上限从 S$3,000 提高至 S$6,000(不包括免赔额)。MOH 预计,新的合规附加险平均比提供最高保障的旧有附加险便宜约 30%,并预计 七家保险公司都会在 2026 年四月前推出合规产品。于 2025 年十一月 27 日或之后购买不合规附加险的保单持有人,必须在 2028 年四月 1 日之后的下一次续保时转换。附加险保费必须全额以现金支付——不能从 MediSave 扣除(MOH,查阅于 2026 年八月)。

政策发展轨迹反映了 MOH 的观点:保险应保障灾难性大额账单,而不是免除日常治疗的全部共同承担费用。投保私立医院 IP 且购买附加险的人,理赔率是未购买附加险者的 1.4 倍,平均理赔金额也是后者的 1.4 倍,加剧了保费和账单不断上涨的“结”,MOH 也正通过费用基准、理赔执法和探讨设立非营利私立医院来应对(MOH,查阅于 2026 年八月)。

选择并维持保障

如果居民能接受在公立医院入住享有津贴的 B2/C 级病房,而且不需要在没有转介的情况下选择专科医生,可能会认为终身健保已经足够;CPF Board 明确将此视为注重成本家庭的默认选择(CPF Board,查阅于 2026 年八月)。若偏好 A 级或 B1 级病房、需要在私立医院就医,或希望不受限制地选择专科医生,则可考虑 IP。决策取决于长期负担能力:保费随年龄上涨,超过额外提款限额的现金补缴会增加,而之后降低保障等级或让保单失效,可能导致私人保险部分受到核保除外条款限制。

居民可以通过 Singpass 登录 CPF Healthcare dashboard 查看保障状况。与保险公司的争议可提交给金融业争议调解中心(FIDReC),该中心依据 MAS 保险法规运作。2020 年至 2023 年间,超过 60 岁的居民中有 2.2% 完全退保 IP,转而只保留终身健保;与此同时,较年轻群体仍持续投保(ST,2024 年四月)。更广泛的医疗融资背景——津贴、MediSave、MediFund 和用于长期残障护理的 CareShield Life——见医疗融资;决定津贴与保险如何相互影响的病房等级和转介机制,见医院以及综合诊疗所和基层医疗。

对综合健保计划的理赔决定提出异议

如果保险公司拒赔或似乎错误计算了医疗保险理赔,保单持有人应先向保险公司提出投诉并提交说明,包括保单号码和相关医疗账单、发票、收据或报告。请保留保险公司的书面回复。FIDReC 要求消费者先联系金融机构;如果金融机构内部争议处理程序未能解决问题,或转交金融机构后已过 四周(以较早者为准),FIDReC 可能受理投诉。消费者必须在收到保险公司的最终回复后不超过 六个月内提交投诉。FIDReC 的保险指南说明,该机构协助个人或独资经营者,并会根据其管辖规则逐案评估;保险公司属于签署参与协议的金融机构(FIDReC,《人寿保险争议消费者指南》,查阅于 2026 年十一月 15 日;FIDReC,《常见问题》,查阅于 2026 年十一月 15 日)。

对于医疗保险投诉,FIDReC 列出的支持文件包括保单合同和附表、与保险公司的往来函件,以及医疗账单、发票、收据和医疗报告;团体医疗保险的保单持有人也可能需要人力资源部门的书面批准。FIDReC 会先提供调解服务;如果调解无法解决争议,消费者可以选择裁决。裁决决定对金融机构有约束力,但对消费者没有约束力;FIDReC 内部没有上诉程序,消费者可以拒绝该决定并寻求其他途径(FIDReC,《支持文件清单》,查阅于 2026 年十一月 15 日;FIDReC,《常见问题》,查阅于 2026 年十一月 15 日)。这些是针对保险公司的争议解决途径;它们没有说明如何更正医院账单或 MediSave/终身健保的申报。